The hedge fund called out a small investment in biotech Coya Therapeutics (COYA), which has just begun clinical trials for a treatment of Lou Gehrig's disease. Greenlight, which is Coya's largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback